{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S1", "tokens": ["LMP1", "Promotes", "Tumor", "Growth", "and", "Survival", "through", "Activation", "of", "Akt", ",", "NFkappaB", ",", "and", "Stat3", "Pathways"], "sentence": "LMP1 Promotes Tumor Growth and Survival through Activation of Akt , NFkappaB , and Stat3 Pathways", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "LMP1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T2", "text": "Akt", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T3", "text": "Stat3", "entity_type": "Protein", "start": 14, "end": 14}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S2", "tokens": ["To", "explore", "which", "pathways", "were", "required", "for", "the", "enhanced", "growth", "and", "survival", "of", "LMP1", "-", "induced", "lymphomas", ",", "splenocytes", "from", "wild-type", "and", "LMP1", "transgenic", "mice", "were", "cultured", "in", "the", "presence", "of", "inhibitors", "for", "Akt", ",", "NFkappaB", ",", "Stat3", ",", "mTOR", ",", "or", "MAPK", "and", "assayed", "for", "growth", "and", "survival", "by", "the", "MTS", "assay", "."], "sentence": "To explore which pathways were required for the enhanced growth and survival of LMP1 - induced lymphomas , splenocytes from wild-type and LMP1 transgenic mice were cultured in the presence of inhibitors for Akt , NFkappaB , Stat3 , mTOR , or MAPK and assayed for growth and survival by the MTS assay .", "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "inhibitors", "start": 31, "end": 31}, "arguments": [{"entity_id": "T6", "text": "Akt", "role": "Theme"}]}, {"id": "E2", "event_type": "Negative_regulation", "trigger": {"text": "inhibitors", "start": 31, "end": 31}, "arguments": [{"entity_id": "T7", "text": "Stat3", "role": "Theme"}]}, {"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "inhibitors", "start": 31, "end": 31}, "arguments": [{"entity_id": "T8", "text": "mTOR", "role": "Theme"}]}], "entity_mentions": [{"id": "T4", "text": "LMP1", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T5", "text": "LMP1", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T6", "text": "Akt", "entity_type": "Protein", "start": 33, "end": 33}, {"id": "T7", "text": "Stat3", "entity_type": "Protein", "start": 37, "end": 37}, {"id": "T8", "text": "mTOR", "entity_type": "Protein", "start": 39, "end": 39}, {"id": "T57", "text": "inhibitors", "entity_type": "Negative_regulation", "start": 31, "end": 31}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "", "tokens": ["As", "previously", "shown", ",", "wild-type", "lymphocytes", "were", "not", "viable", "in", "culture", "and", "could", "not", "be", "tested", "with", "the", "inhibitors", "."], "sentence": "As previously shown , wild-type lymphocytes were not viable in culture and could not be tested with the inhibitors .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S4", "tokens": ["However", ",", "the", "enhanced", "viability", "of", "LMP1", "transgenic", "lymphocytes", "was", "effectively", "blocked", "by", "treatment", "with", "triciribine", ",", "BAY11-7085", ",", "cucurbitacin", "I", ",", "and", "slightly", "with", "SB203580", ",", "but", "not", "by", "treatment", "with", "rapamycin", ",", "U0126", ",", "or", "AG490", "(", "Figure", "7", ")", "."], "sentence": "However , the enhanced viability of LMP1 transgenic lymphocytes was effectively blocked by treatment with triciribine , BAY11-7085 , cucurbitacin I , and slightly with SB203580 , but not by treatment with rapamycin , U0126 , or AG490 ( Figure 7 ) .", "event_mentions": [], "entity_mentions": [{"id": "T9", "text": "LMP1", "entity_type": "Protein", "start": 6, "end": 6}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S5", "tokens": ["Triciribine", "inhibits", "the", "activation", "of", "Akt", "and", "at", "20", "muM", "has", "been", "shown", "to", "induce", "growth", "arrest", "in", "cancer", "cells", "with", "aberrant", "Akt", "activity", "[", "46", "]", "."], "sentence": "Triciribine inhibits the activation of Akt and at 20 muM has been shown to induce growth arrest in cancer cells with aberrant Akt activity [ 46 ] .", "event_mentions": [{"id": "E4", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 1, "end": 1}, "arguments": [{"entity_id": "T59", "text": "activation", "role": "Theme"}]}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 3, "end": 3}, "arguments": [{"entity_id": "T10", "text": "Akt", "role": "Theme"}]}], "entity_mentions": [{"id": "T10", "text": "Akt", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T11", "text": "Akt", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T58", "text": "inhibits", "entity_type": "Negative_regulation", "start": 1, "end": 1}, {"id": "T59", "text": "activation", "entity_type": "Positive_regulation", "start": 3, "end": 3}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S6", "tokens": ["The", "effects", "of", "triciribine", "on", "cell", "growth", "of", "the", "transgenic", "lymphocytes", "and", "lymphomas", "were", "apparent", "as", "low", "as", "1", "muM", ",", "suggesting", "that", "activation", "of", "Akt", "is", "required", "for", "the", "survival", "and", "growth", "of", "LMP1", "transgenic", "lymphocytes", "and", "lymphoma", "cells", "(", "Figure", "7", ")", "."], "sentence": "The effects of triciribine on cell growth of the transgenic lymphocytes and lymphomas were apparent as low as 1 muM , suggesting that activation of Akt is required for the survival and growth of LMP1 transgenic lymphocytes and lymphoma cells ( Figure 7 ) .", "event_mentions": [{"id": "E6", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 23, "end": 23}, "arguments": [{"entity_id": "T12", "text": "Akt", "role": "Theme"}]}], "entity_mentions": [{"id": "T12", "text": "Akt", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T13", "text": "LMP1", "entity_type": "Protein", "start": 34, "end": 34}, {"id": "T60", "text": "activation", "entity_type": "Positive_regulation", "start": 23, "end": 23}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S7", "tokens": ["The", "effects", "of", "the", "inhibitors", "were", "assessed", "by", "identifying", "phosphorylated", "Akt", ",", "Stat3", ",", "and", "total", "levels", "of", "IkappaBalpha", "(", "Figure", "8", ")", "."], "sentence": "The effects of the inhibitors were assessed by identifying phosphorylated Akt , Stat3 , and total levels of IkappaBalpha ( Figure 8 ) .", "event_mentions": [{"id": "E7", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylated", "start": 9, "end": 9}, "arguments": [{"entity_id": "T14", "text": "Akt", "role": "Theme"}]}, {"id": "E8", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylated", "start": 9, "end": 9}, "arguments": [{"entity_id": "T15", "text": "Stat3", "role": "Theme"}]}], "entity_mentions": [{"id": "T14", "text": "Akt", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T15", "text": "Stat3", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T16", "text": "IkappaBalpha", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T61", "text": "phosphorylated", "entity_type": "Phosphorylation", "start": 9, "end": 9}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S8", "tokens": ["Treatment", "with", "triciribine", "effectively", "blocked", "phosphorylation", "of", "Akt", ",", "and", "phosphorylated", "Akt", "was", "no", "longer", "detected", "past", "5", "muM", "."], "sentence": "Treatment with triciribine effectively blocked phosphorylation of Akt , and phosphorylated Akt was no longer detected past 5 muM .", "event_mentions": [{"id": "E9", "event_type": "Negative_regulation", "trigger": {"text": "blocked", "start": 4, "end": 4}, "arguments": [{"entity_id": "T63", "text": "phosphorylation", "role": "Theme"}]}, {"id": "E10", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylation", "start": 5, "end": 5}, "arguments": [{"entity_id": "T17", "text": "Akt", "role": "Theme"}]}, {"id": "E11", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylated", "start": 10, "end": 10}, "arguments": [{"entity_id": "T18", "text": "Akt", "role": "Theme"}]}, {"id": "E12", "event_type": "Positive_regulation", "trigger": {"text": "detected", "start": 15, "end": 15}, "arguments": [{"entity_id": "T64", "text": "phosphorylated", "role": "Theme"}]}], "entity_mentions": [{"id": "T17", "text": "Akt", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T18", "text": "Akt", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T62", "text": "blocked", "entity_type": "Negative_regulation", "start": 4, "end": 4}, {"id": "T63", "text": "phosphorylation", "entity_type": "Phosphorylation", "start": 5, "end": 5}, {"id": "T64", "text": "phosphorylated", "entity_type": "Phosphorylation", "start": 10, "end": 10}, {"id": "T65", "text": "detected", "entity_type": "Positive_regulation", "start": 15, "end": 15}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S9", "tokens": ["Phosphorylated", "Stat3", "and", "IkappaBalpha", "were", "still", "present", "at", "25", "muM", "."], "sentence": "Phosphorylated Stat3 and IkappaBalpha were still present at 25 muM .", "event_mentions": [{"id": "E13", "event_type": "Phosphorylation", "trigger": {"text": "Phosphorylated", "start": 0, "end": 0}, "arguments": [{"entity_id": "T19", "text": "Stat3", "role": "Theme"}]}, {"id": "E14", "event_type": "Phosphorylation", "trigger": {"text": "Phosphorylated", "start": 0, "end": 0}, "arguments": [{"entity_id": "T20", "text": "IkappaBalpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T19", "text": "Stat3", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T20", "text": "IkappaBalpha", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T66", "text": "Phosphorylated", "entity_type": "Phosphorylation", "start": 0, "end": 0}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S10", "tokens": ["These", "findings", "suggest", "that", "triciribine", "specifically", "targets", "Akt", "and", "that", "Akt", "activation", "is", "required", "for", "the", "enhanced", "viability", "of", "the", "transgenic", "lymphocytes", "and", "lymphoma", "cells", "."], "sentence": "These findings suggest that triciribine specifically targets Akt and that Akt activation is required for the enhanced viability of the transgenic lymphocytes and lymphoma cells .", "event_mentions": [{"id": "E15", "event_type": "Regulation", "trigger": {"text": "targets", "start": 6, "end": 6}, "arguments": [{"entity_id": "T21", "text": "Akt", "role": "Theme"}]}, {"id": "E16", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 11, "end": 11}, "arguments": [{"entity_id": "T22", "text": "Akt", "role": "Theme"}]}], "entity_mentions": [{"id": "T21", "text": "Akt", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T22", "text": "Akt", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T67", "text": "targets", "entity_type": "Regulation", "start": 6, "end": 6}, {"id": "T68", "text": "activation", "entity_type": "Positive_regulation", "start": 11, "end": 11}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "", "tokens": ["Inhibition", "of", "NFkappaB", "signaling", "rapidly", "induces", "cell", "death", "of", "EBV-transformed", "lymphocytes", "[", "17", ",", "18", "]", "."], "sentence": "Inhibition of NFkappaB signaling rapidly induces cell death of EBV-transformed lymphocytes [ 17 , 18 ] .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S12", "tokens": ["BAY11-7085", ",", "an", "inhibitor", "of", "NFkappaB", "signaling", ",", "also", "greatly", "decreased", "the", "viability", "of", "the", "LMP1", "transgenic", "lymphocytes", "and", "lymphoma", "cells", "at", "doses", "as", "low", "as", "1", "muM", ",", "and", "at", "5", "muM", "the", "cells", "were", "completely", "nonviable", "(", "Figure", "7", ")", "."], "sentence": "BAY11-7085 , an inhibitor of NFkappaB signaling , also greatly decreased the viability of the LMP1 transgenic lymphocytes and lymphoma cells at doses as low as 1 muM , and at 5 muM the cells were completely nonviable ( Figure 7 ) .", "event_mentions": [], "entity_mentions": [{"id": "T23", "text": "LMP1", "entity_type": "Protein", "start": 15, "end": 15}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "", "tokens": ["This", "is", "well", "within", "the", "reported", "IC50", "of", "10", "muM", "."], "sentence": "This is well within the reported IC50 of 10 muM .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S14", "tokens": ["Phosphorylated", "Akt", ",", "Stat3", ",", "and", "total", "IkappaBalpha", "were", "still", "present", "up", "to", "treatment", "with", "15", "muM", "and", "then", "were", "no", "longer", "detected", "(", "Figure", "8", ")", "."], "sentence": "Phosphorylated Akt , Stat3 , and total IkappaBalpha were still present up to treatment with 15 muM and then were no longer detected ( Figure 8 ) .", "event_mentions": [{"id": "E17", "event_type": "Phosphorylation", "trigger": {"text": "Phosphorylated", "start": 0, "end": 0}, "arguments": [{"entity_id": "T24", "text": "Akt", "role": "Theme"}]}, {"id": "E18", "event_type": "Phosphorylation", "trigger": {"text": "Phosphorylated", "start": 0, "end": 0}, "arguments": [{"entity_id": "T25", "text": "Stat3", "role": "Theme"}]}, {"id": "E19", "event_type": "Positive_regulation", "trigger": {"text": "present", "start": 10, "end": 10}, "arguments": [{"entity_id": "T69", "text": "Phosphorylated", "role": "Theme"}]}, {"id": "E20", "event_type": "Positive_regulation", "trigger": {"text": "present", "start": 10, "end": 10}, "arguments": [{"entity_id": "T69", "text": "Phosphorylated", "role": "Theme"}]}, {"id": "E21", "event_type": "Positive_regulation", "trigger": {"text": "present", "start": 10, "end": 10}, "arguments": [{"entity_id": "T26", "text": "IkappaBalpha", "role": "Theme"}]}, {"id": "E22", "event_type": "Positive_regulation", "trigger": {"text": "detected", "start": 22, "end": 22}, "arguments": [{"entity_id": "T69", "text": "Phosphorylated", "role": "Theme"}]}, {"id": "E23", "event_type": "Positive_regulation", "trigger": {"text": "detected", "start": 22, "end": 22}, "arguments": [{"entity_id": "T69", "text": "Phosphorylated", "role": "Theme"}]}, {"id": "E24", "event_type": "Positive_regulation", "trigger": {"text": "detected", "start": 22, "end": 22}, "arguments": [{"entity_id": "T26", "text": "IkappaBalpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T24", "text": "Akt", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T25", "text": "Stat3", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T26", "text": "IkappaBalpha", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T69", "text": "Phosphorylated", "entity_type": "Phosphorylation", "start": 0, "end": 0}, {"id": "T70", "text": "present", "entity_type": "Positive_regulation", "start": 10, "end": 10}, {"id": "T71", "text": "detected", "entity_type": "Positive_regulation", "start": 22, "end": 22}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S15", "tokens": ["This", "finding", "suggests", "that", "inhibition", "of", "NFkappaB", "can", "induce", "cell", "death", "in", "LMP1", "transgenic", "lymphocytes", "and", "lymphoma", "cells", "without", "significant", "effects", "on", "activation", "of", "Akt", "or", "Stat3", "."], "sentence": "This finding suggests that inhibition of NFkappaB can induce cell death in LMP1 transgenic lymphocytes and lymphoma cells without significant effects on activation of Akt or Stat3 .", "event_mentions": [{"id": "E25", "event_type": "Regulation", "trigger": {"text": "effects", "start": 20, "end": 20}, "arguments": [{"entity_id": "T73", "text": "activation", "role": "Theme"}]}, {"id": "E27", "event_type": "Regulation", "trigger": {"text": "effects", "start": 20, "end": 20}, "arguments": [{"entity_id": "T73", "text": "activation", "role": "Theme"}]}, {"id": "E26", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 22, "end": 22}, "arguments": [{"entity_id": "T28", "text": "Akt", "role": "Theme"}]}, {"id": "E28", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 22, "end": 22}, "arguments": [{"entity_id": "T29", "text": "Stat3", "role": "Theme"}]}], "entity_mentions": [{"id": "T27", "text": "LMP1", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T28", "text": "Akt", "entity_type": "Protein", "start": 24, "end": 24}, {"id": "T29", "text": "Stat3", "entity_type": "Protein", "start": 26, "end": 26}, {"id": "T72", "text": "effects", "entity_type": "Regulation", "start": 20, "end": 20}, {"id": "T73", "text": "activation", "entity_type": "Positive_regulation", "start": 22, "end": 22}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S16", "tokens": ["Cucurbitacin", "I", "inhibits", "activation", "of", "Stat3", "by", "suppressing", "the", "activation", "of", "its", "kinase", "JAK2", "."], "sentence": "Cucurbitacin I inhibits activation of Stat3 by suppressing the activation of its kinase JAK2 .", "event_mentions": [{"id": "E29", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 2, "end": 2}, "arguments": [{"entity_id": "T75", "text": "activation", "role": "Theme"}]}, {"id": "E30", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 3, "end": 3}, "arguments": [{"entity_id": "T30", "text": "Stat3", "role": "Theme"}]}], "entity_mentions": [{"id": "T30", "text": "Stat3", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T31", "text": "JAK2", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T74", "text": "inhibits", "entity_type": "Negative_regulation", "start": 2, "end": 2}, {"id": "T75", "text": "activation", "entity_type": "Positive_regulation", "start": 3, "end": 3}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S17", "tokens": ["It", "has", "been", "shown", "to", "selectively", "inhibit", "the", "growth", "of", "tumors", "with", "constitutively", "activated", "Stat3", "[", "47", "]", "."], "sentence": "It has been shown to selectively inhibit the growth of tumors with constitutively activated Stat3 [ 47 ] .", "event_mentions": [{"id": "E31", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 13, "end": 13}, "arguments": [{"entity_id": "T32", "text": "Stat3", "role": "Theme"}]}], "entity_mentions": [{"id": "T32", "text": "Stat3", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T76", "text": "activated", "entity_type": "Positive_regulation", "start": 13, "end": 13}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S18", "tokens": ["Similarly", ",", "LMP1", "transgenic", "lymphocytes", "and", "lymphoma", "cells", "were", "susceptible", "to", "cucurbitacin", "I", "treatment", "starting", "at", "0.1", "muM", ",", "a", "dose", "that", "corresponds", "closely", "to", "the", "reported", "IC50", "of", "500", "nM", "(", "Figure", "7", ")", "[", "47", "]", "."], "sentence": "Similarly , LMP1 transgenic lymphocytes and lymphoma cells were susceptible to cucurbitacin I treatment starting at 0.1 muM , a dose that corresponds closely to the reported IC50 of 500 nM ( Figure 7 ) [ 47 ] .", "event_mentions": [], "entity_mentions": [{"id": "T33", "text": "LMP1", "entity_type": "Protein", "start": 2, "end": 2}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S19", "tokens": ["Phosphorylated", "Akt", ",", "Stat3", ",", "and", "total", "IkappaBalpha", "were", "not", "detectable", "past", "1", "muM", "and", "at", "higher", "doses", "all", "protein", "levels", "were", "greatly", "decreased", ",", "indicative", "of", "the", "total", "loss", "of", "viability", "(", "Figure", "8", ")", "."], "sentence": "Phosphorylated Akt , Stat3 , and total IkappaBalpha were not detectable past 1 muM and at higher doses all protein levels were greatly decreased , indicative of the total loss of viability ( Figure 8 ) .", "event_mentions": [{"id": "E32", "event_type": "Phosphorylation", "trigger": {"text": "Phosphorylated", "start": 0, "end": 0}, "arguments": [{"entity_id": "T34", "text": "Akt", "role": "Theme"}]}, {"id": "E33", "event_type": "Phosphorylation", "trigger": {"text": "Phosphorylated", "start": 0, "end": 0}, "arguments": [{"entity_id": "T35", "text": "Stat3", "role": "Theme"}]}, {"id": "E34", "event_type": "Positive_regulation", "trigger": {"text": "detectable", "start": 10, "end": 10}, "arguments": [{"entity_id": "T34", "text": "Akt", "role": "Theme"}]}, {"id": "E35", "event_type": "Positive_regulation", "trigger": {"text": "detectable", "start": 10, "end": 10}, "arguments": [{"entity_id": "T35", "text": "Stat3", "role": "Theme"}]}, {"id": "E36", "event_type": "Positive_regulation", "trigger": {"text": "detectable", "start": 10, "end": 10}, "arguments": [{"entity_id": "T36", "text": "IkappaBalpha", "role": "Theme"}]}, {"id": "E37", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 23, "end": 23}, "arguments": [{"entity_id": "T34", "text": "Akt", "role": "Theme"}]}, {"id": "E38", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 23, "end": 23}, "arguments": [{"entity_id": "T35", "text": "Stat3", "role": "Theme"}]}, {"id": "E39", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 23, "end": 23}, "arguments": [{"entity_id": "T36", "text": "IkappaBalpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T34", "text": "Akt", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T35", "text": "Stat3", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T36", "text": "IkappaBalpha", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T77", "text": "Phosphorylated", "entity_type": "Phosphorylation", "start": 0, "end": 0}, {"id": "T78", "text": "detectable", "entity_type": "Positive_regulation", "start": 10, "end": 10}, {"id": "T79", "text": "decreased", "entity_type": "Negative_regulation", "start": 23, "end": 23}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S20", "tokens": ["A", "second", "reported", "inhibitor", "of", "Stat3", ",", "AG490", ",", "had", "no", "effect", "on", "growth", "(", "Figure", "7", ")", ",", "but", "activation", "of", "Akt", ",", "Stat3", ",", "or", "levels", "of", "IkappaBalpha", "were", "also", "not", "affected", "(", "Figure", "8", ")", "."], "sentence": "A second reported inhibitor of Stat3 , AG490 , had no effect on growth ( Figure 7 ) , but activation of Akt , Stat3 , or levels of IkappaBalpha were also not affected ( Figure 8 ) .", "event_mentions": [{"id": "E40", "event_type": "Negative_regulation", "trigger": {"text": "inhibitor", "start": 3, "end": 3}, "arguments": [{"entity_id": "T37", "text": "Stat3", "role": "Theme"}]}, {"id": "E41", "event_type": "Regulation", "trigger": {"text": "affected", "start": 33, "end": 33}, "arguments": [{"entity_id": "T40", "text": "IkappaBalpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T37", "text": "Stat3", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T38", "text": "Akt", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T39", "text": "Stat3", "entity_type": "Protein", "start": 24, "end": 24}, {"id": "T40", "text": "IkappaBalpha", "entity_type": "Protein", "start": 29, "end": 29}, {"id": "T80", "text": "inhibitor", "entity_type": "Negative_regulation", "start": 3, "end": 3}, {"id": "T81", "text": "affected", "entity_type": "Regulation", "start": 33, "end": 33}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S21", "tokens": ["These", "findings", "suggest", "that", "inhibition", "of", "Stat3", "can", "induce", "cell", "death", "in", "LMP1", "transgenic", "lymphocytes", "and", "lymphoma", "cells", ",", "but", "Stat3", "inhibition", "also", "has", "considerable", "crossover", "effects", "on", "Akt", "and", "NFkappaB", "signaling", "."], "sentence": "These findings suggest that inhibition of Stat3 can induce cell death in LMP1 transgenic lymphocytes and lymphoma cells , but Stat3 inhibition also has considerable crossover effects on Akt and NFkappaB signaling .", "event_mentions": [{"id": "E42", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 4, "end": 4}, "arguments": [{"entity_id": "T41", "text": "Stat3", "role": "Theme"}]}, {"id": "E43", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 21, "end": 21}, "arguments": [{"entity_id": "T43", "text": "Stat3", "role": "Theme"}]}], "entity_mentions": [{"id": "T41", "text": "Stat3", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T42", "text": "LMP1", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T43", "text": "Stat3", "entity_type": "Protein", "start": 20, "end": 20}, {"id": "T44", "text": "Akt", "entity_type": "Protein", "start": 28, "end": 28}, {"id": "T82", "text": "inhibition", "entity_type": "Negative_regulation", "start": 4, "end": 4}, {"id": "T83", "text": "inhibition", "entity_type": "Negative_regulation", "start": 21, "end": 21}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S22", "tokens": ["LMP1", "has", "also", "been", "shown", "to", "activate", "JNK", "and", "p38", "MAPK", "pathways", "[", "13", ",", "48", "]", ",", "and", "LMP1", "transgenic", "lymphocytes", "were", "mildly", "susceptible", "to", "growth", "inhibition", "by", "SB202190", ",", "an", "inhibitor", "of", "p38", "MAPK", ",", "but", "not", "U0126", ",", "an", "inhibitor", "of", "MEK1", "/", "2", "activity", "."], "sentence": "LMP1 has also been shown to activate JNK and p38 MAPK pathways [ 13 , 48 ] , and LMP1 transgenic lymphocytes were mildly susceptible to growth inhibition by SB202190 , an inhibitor of p38 MAPK , but not U0126 , an inhibitor of MEK1 / 2 activity .", "event_mentions": [{"id": "E44", "event_type": "Negative_regulation", "trigger": {"text": "inhibitor", "start": 42, "end": 42}, "arguments": [{"entity_id": "T47", "text": "MEK1", "role": "Theme"}]}, {"id": "E45", "event_type": "Negative_regulation", "trigger": {"text": "inhibitor", "start": 42, "end": 42}, "arguments": [{"entity_id": "T48", "text": "2", "role": "Theme"}]}], "entity_mentions": [{"id": "T45", "text": "LMP1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T46", "text": "LMP1", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T47", "text": "MEK1", "entity_type": "Protein", "start": 44, "end": 44}, {"id": "T48", "text": "2", "entity_type": "Protein", "start": 46, "end": 46}, {"id": "T84", "text": "inhibitor", "entity_type": "Negative_regulation", "start": 42, "end": 42}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S23", "tokens": ["However", ",", "effects", "of", "SB202190", "were", "only", "apparent", "at", "high", "doses", "(", ">", "10", "muM", ")", ",", "much", "higher", "than", "the", "reported", "IC50", "of", "0.35", "muM", ",", "suggesting", "that", "p38", "MAPK", "does", "not", "significantly", "contribute", "to", "the", "enhanced", "viability", "in", "LMP1", "transgenic", "lymphocytes", "or", "lymphoma", "cells", "(", "Figure", "7", ")", "."], "sentence": "However , effects of SB202190 were only apparent at high doses ( > 10 muM ) , much higher than the reported IC50 of 0.35 muM , suggesting that p38 MAPK does not significantly contribute to the enhanced viability in LMP1 transgenic lymphocytes or lymphoma cells ( Figure 7 ) .", "event_mentions": [], "entity_mentions": [{"id": "T49", "text": "LMP1", "entity_type": "Protein", "start": 40, "end": 40}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S24", "tokens": ["Interestingly", ",", "both", "wild-type", "and", "LMP1", "transgenic", "lymphomas", "were", "similarly", "susceptible", "to", "triciribine", ",", "BAY11-7085", ",", "and", "cucurbitacin", "I", "treatments", ",", "but", "not", "SB202190", ",", "AG490", ",", "or", "U0126", "treatment", ",", "suggesting", "that", "activation", "of", "Akt", ",", "NFkappaB", ",", "and", "Stat3", "but", "not", "MAPK", "pathways", "are", "characteristics", "associated", "with", "malignant", "transformation", "(", "Figure", "7", ")", "."], "sentence": "Interestingly , both wild-type and LMP1 transgenic lymphomas were similarly susceptible to triciribine , BAY11-7085 , and cucurbitacin I treatments , but not SB202190 , AG490 , or U0126 treatment , suggesting that activation of Akt , NFkappaB , and Stat3 but not MAPK pathways are characteristics associated with malignant transformation ( Figure 7 ) .", "event_mentions": [], "entity_mentions": [{"id": "T50", "text": "LMP1", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T51", "text": "Akt", "entity_type": "Protein", "start": 35, "end": 35}, {"id": "T52", "text": "Stat3", "entity_type": "Protein", "start": 40, "end": 40}]}
{"doc_id": "PMC-2065877-08-Results-07.txt", "sent_id": "S25", "tokens": ["rapamycin", ",", "an", "inhibitor", "of", "mTOR", ",", "did", "not", "affect", "the", "viability", "of", "the", "transgenic", "lymphocytes", "or", "lymphoma", "cells", ",", "confirming", "that", "mTOR", "is", "not", "targeted", "by", "Akt", "activation", "in", "LMP1", "transgenic", "lymphocytes", "or", "malignant", "lymphoma", "cells", "(", "Figure", "7", ")", "."], "sentence": "rapamycin , an inhibitor of mTOR , did not affect the viability of the transgenic lymphocytes or lymphoma cells , confirming that mTOR is not targeted by Akt activation in LMP1 transgenic lymphocytes or malignant lymphoma cells ( Figure 7 ) .", "event_mentions": [{"id": "E46", "event_type": "Negative_regulation", "trigger": {"text": "inhibitor", "start": 3, "end": 3}, "arguments": [{"entity_id": "T53", "text": "mTOR", "role": "Theme"}]}, {"id": "E47", "event_type": "Regulation", "trigger": {"text": "targeted", "start": 25, "end": 25}, "arguments": [{"entity_id": "T54", "text": "mTOR", "role": "Theme"}]}], "entity_mentions": [{"id": "T53", "text": "mTOR", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T54", "text": "mTOR", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T55", "text": "Akt", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T56", "text": "LMP1", "entity_type": "Protein", "start": 30, "end": 30}, {"id": "T85", "text": "inhibitor", "entity_type": "Negative_regulation", "start": 3, "end": 3}, {"id": "T86", "text": "targeted", "entity_type": "Regulation", "start": 25, "end": 25}]}
